Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
End Stage Renal Disease
Interventions
DEVICE

Theranova Dialyzer

The Theranova dialyzer will be used for each of the hemodialysis treatments beginning week 3 and ending at the end of the dialysis week on week 14 and again starting week 23 and ending at the end of the dialysis week on week 46 . This will allow us to compare patient reported symptoms in weeks 1 and 2 when patients are on their usual dialyzer with their symptoms using the Theranova dialyzer. This will also allow us to see if there is a carry-over effect.

Trial Locations (2)

N6A 5W9

Adam Linton Dialysis Unit, London

N6K 1M6

Kidney Care Centre, London

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03640858 - Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL | Biotech Hunter | Biotech Hunter